Cue Biopharma (CUE) PT Lowered to $4 at Jefferies
Tweet Send to a Friend
Jefferies analyst Maury Raycroft lowered the price target on Cue Biopharma (NASDAQ: CUE) to $4.00 (from $6.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
